GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.350
+0.030 (0.69%)
At close: May 12, 2025, 4:00 PM
4.400
+0.050 (1.15%)
After-hours: May 12, 2025, 7:06 PM EDT
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $1.67 billion as of May 12, 2025. Its market cap has decreased by -36.06% in one year.
Market Cap
1.67B
Enterprise Value
1.91B
1-Year Change
-36.06%
Ranking
Category
Stock Price
$4.35
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $1.67B, a decrease of -86.83%. That is a compound annual growth rate of -35.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 1.66B | -7.38% |
| Dec 31, 2024 | 1.79B | -34.24% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.34B |
| Johnson & Johnson | 370.97B |
| UnitedHealth Group | 344.07B |
| AbbVie | 337.81B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.33B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |